Scientific Papers

Associations of the triglyceride-glucose index and remnant cholesterol with coronary artery disease: a retrospective study | Lipids in Health and Disease

Description of Image

  • Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982–3021.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399:1347–58.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sincer I, Gunes Y, Mansiroglu AK, Cosgun M, Aktas G. Association of mean platelet volume and red blood cell distribution width with coronary collateral development in stable coronary artery disease. Postepy Kardiol Interwencyjnej. 2018;14:263–9.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 1992;2019(65):9–15.


    Google Scholar
     

  • Aktas G, Khalid A, Kurtkulagi O, Duman TT, Bilgin S, Kahveci G, Atak Tel BM, Sincer I, Gunes Y. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134:297–302.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23:1098–102.

    Article 
    PubMed 

    Google Scholar
     

  • Kosekli MA, Kurtkulagii O, Kahveci G, Duman TT, Tel BMA, Bilgin S, Demirkol ME, Aktas G. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 1992;2021(67):549–54.


    Google Scholar
     

  • Aktas G, Kocak MZ, Taslamacioglu Duman T, Erkus E, Atak BM, Sit M, Savli H. Mean Platelet Volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Med J. 2018;7:650–3.

  • Aktas G, Yilmaz S, Kantarci DB, Duman TT, Bilgin S, Balci SB, Atak Tel BM. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135:519–23.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Vahatalo JH, Huikuri HV, Holmstrom LTA, Kentta TV, Haukilahti MAE, Pakanen L, Kaikkonen KS, Tikkanen J, Perkiomaki JS, Myerburg RJ, Junttila MJ. Association of silent myocardial infarction and sudden cardiac death. JAMA Cardiol. 2019;4:796–802.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Jin P, Wang F. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21:168.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jepsen AM, Langsted A, Varbo A, Bang LE, Kamstrup PR, Nordestgaard BG. Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease. Clin Chem. 2016;62:593–604.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ginsberg HN, Packard CJ, Chapman MJ, Boren J, Aguilar-Salinas CA, Averna M, Ference BA, Gaudet D, Hegele RA, Kersten S, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42:4791–806.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Doi T, Langsted A, Nordestgaard BG. Elevated remnant cholesterol reclassifies risk of ischemic heart disease and myocardial infarction. J Am Coll Cardiol. 2022;79:2383–97.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Varbo A, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128:1298–309.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Varbo A, Benn M, Nordestgaard BG. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol Ther. 2014;141:358–67.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Varbo A, Nordestgaard BG. Remnant lipoproteins. Curr Opin Lipidol. 2017;28:300–7.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Moens SJB, Verweij SL, Schnitzler JG, Stiekema LCA, Bos M, Langsted A, Kuijk C, Bekkering S, Voermans C, Verberne HJ, et al. Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans. Arterioscler Thromb Vasc Biol. 2017;37:969.

    Article 

    Google Scholar
     

  • Song Y, Cui K, Yang M, Song C, Yin D, Dong Q, Gao Y, Dou K. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Cardiovasc Diabetol. 2023;22:180.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liu Y, Zhu B, Zhou W, Du Y, Qi D, Wang C, Cheng Q, Zhang Y, Wang S, Gao C. Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension. Cardiovasc Diabetol. 2023;22:133.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yu H, Tao L, Li YG, Yang L, Liu D, Wang Y, Hao X, He H, Che Y, Wang P, et al. Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression. Cardiovasc Diabetol. 2023;22:130.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21:68.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7:216.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bilgin S, Aktas G, Atak T, Kurtkulagi O, Kahveci G, Duman T, Akin H, Balci B, Erturk A. Triglyceride to high density lipoprotein cholesterol ratio is elevated in patients with complicated type 2 diabetes mellitus. Acta Facultatis Medicae Naissensis. 2022;39:66–73.

    Article 
    CAS 

    Google Scholar
     

  • Kurtkulagi O, Bilgin S, Kahveci GB, Tel BMA, Kosekli MA. Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis? Exp Biomed Res. 2021;4:224–9.

    Article 
    CAS 

    Google Scholar
     

  • Kurtkulagi O, Aktas G, Taslamacioglu Duman T, Bilgin S, Atak Tel BM, Kahveci G. Correlation between serum triglyceride to HDL cholesterol ratio and blood pressure in patients with primary hypertension. Precision Medical Sci. 2022;11:100–5.

    Article 
    CAS 

    Google Scholar
     

  • Aktas G. Letter regarding “Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults.” Biomol Biomed. 2023;23:187.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255–323.

    Article 
    PubMed 

    Google Scholar
     

  • Simental-Mendia LE, Guerrero-Romero F. The correct formula for the triglycerides and glucose index. Eur J Pediatr. 2020;179:1171.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cordero A, Alvarez-Alvarez B, Escribano D, Garcia-Acuna JM, Cid-Alvarez B, Rodriguez-Manero M, Quintanilla MA, Agra-Bermejo R, Zuazola P, Gonzalez-Juanatey JR. Remnant cholesterol in patients admitted for acute coronary syndromes. Eur J Prev Cardiol. 2023;30:340–8.

    Article 
    PubMed 

    Google Scholar
     

  • Shao Q, Yang Z, Wang Y, Li Q, Han K, Liang J, Shen H, Liu X, Zhou Y, Ma X, Wang Z. Elevated remnant cholesterol is associated with adverse cardiovascular outcomes in patients with acute coronary syndrome. J Atheroscler Thromb. 2022;29:1808–22.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cao YX, Zhang HW, Jin JL, Liu HH, Zhang Y, Gao Y, Guo YL, Wu NQ, Hua Q, Li YF, et al. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes. Cardiovasc Diabetol. 2020;19:104.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ohmura H. Contribution of remnant cholesterol to coronary atherosclerosis. J Atheroscler Thromb. 2022;29:1706–8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mancusi C, de Simone G, Best LG, Wang W, Zhang Y, Roman MJ, Lee ET, Howard BV, Devereux RB. Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the Strong Heart Study cohort. Cardiovasc Diabetol. 2019;18:56.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhao Q, Cheng YJ, Xu YK, Zhao ZW, Liu C, Sun TN, Zhou YJ. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20:190.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Huang R, Lin Y, Ye X, Zhong X, Xie P, Li M, Zhuang X, Liao X. Triglyceride-glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study. Eur J Prev Cardiol. 2022;29:1531–41.

    Article 
    PubMed 

    Google Scholar
     

  • Thai PV, Tien HA, Van Minh H, Valensi P. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2020;19:137.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang S, Shi J, Peng Y, Fang Q, Mu Q, Gu W, Hong J, Zhang Y, Wang W. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study. Cardiovasc Diabetol. 2021;20:82.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10:293–302.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Description of Image

    Source link